EpiPen

Filter by Popularity: - - - -
Searching for "EpiPen"
Thumbnail
Adrenaline injection devices that were branded "inherently unsafe" by a coroner after the inquest of Natasha Ednan-Laperouse, the teenager who died after eating a Pret... [Read More]
Thumbnail
Sandoz Inc. plans to start selling its generic version early next year... [Read More]
Thumbnail
Test your knowledge with amazing and interesting facts, trivia, quizzes, and brain teaser games on MentalFloss.com. [Read More]
Thumbnail
Adamis and Sandoz announce an expected SYMJEPI launch in Q1 2019. Sandoz announces SYMJEPI's WAC of $250 vs. $300 for Mylan's and Teva's generic EpiPen.... [Read More]
Thumbnail
Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year. [Read More]
Thumbnail
Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems. [Read More]
Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year.The EpiPen injector is used to... [Read More]
Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year.The EpiPen injector is used to... [Read More]
Thumbnail
Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year. [Read More]
Thumbnail
Sandoz will sell pre-filled syringes with epinephrine for $250 a pair without insurance. [Read More]
Tags: Third - EpiPen - Sandoz
Sandoz will sell a pair of injectors, under the name Symjepi, for $250 without insurance. [Read More]
Thumbnail
Generic drugmaker Sandoz to sell prefilled syringe alternative to EpiPen emergency allergy medication. [Read More]
Novartis AG said its U.S. unit Sandoz Inc will launch Adamis Pharmaceuticals Corp's emergency allergy shots next year in the United States, at a price... [Read More]
A generic drugmaker plans to start selling a slightly cheaper version of the EpiPen in the U.S. early next year. The penlike injectors are... [Read More]
Thumbnail
Drugmaker Sandoz to sell slightly cheaper generic rival of EpiPen emergency allergy medication. [Read More]
Thumbnail
A generic drugmaker plans to start selling a slightly cheaper version of the EpiPen in the U.S. early next year. [Read More]
The Thursday announcement shows an end in sight for the 17-month saga that has stretched since Symjepi was first approved by U.S. regulators. [Read More]
Tags: Drug - Novartis - EpiPen
Thumbnail
Generic drugmaker Sandoz announced plans Thursday to start selling a slightly cheaper version of the EpiPen in the U.S. early next year. [Read More]
Thumbnail
Novartis' Sandoz expects to launch an EpiPen rival in the first quarter of 2019. A two-pack will cost $250, which is less than other EpiPen... [Read More]
Thumbnail
WASHINGTON—Two U.S. senators from opposite sides of the aisle are proposing legislation that would close a loophole in the Medicaid rebate program that allowed Mylan... [Read More]
Jump To: